Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair
- Chang-Goo Huh*,
- Valentina M. Factor*,
- Aránzazu Sánchez,
- Koichi Uchida,
- Elizabeth A. Conner, and
- Snorri S. Thorgeirsson†
- Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive MSC 4262, Building 37, Room 4146A, Bethesda, MD 20892-4262
-
Edited by George F. Vande Woude, Van Andel Research Institute, Grand Rapids, MI, and approved January 16, 2004 (received for review September 22, 2003)
Abstract
Hepatocyte growth factor/scatter factor c-met signaling pathway is of central importance during development as well as in tumorigenesis. Because homozygous null mice for either hgf/sf or c-met die in utero, we used Cre/loxP-mediated gene targeting to investigate the function of c-met specifically in the adult liver. Loss of c-met appeared not to be detrimental to hepatocyte function under physiological conditions. Nonetheless, the adaptive responses of the liver to injury were dramatically affected. Mice lacking c-met gene in hepatocytes were hypersensitive to Fas-induced apoptosis. When injected with a low dose of anti-Fas antibody, the majority of these mice died from massive apoptosis and hemorrhagic necrosis, whereas all wild-type mice survived with signs of minor injury. After a challenge with a single necrogenic dose of CCl4, c-met conditional knockout mice exhibited impaired recovery from centrolobular lesions rather than a deficit in hepatocyte proliferation. The delayed healing was associated with a persistent inflammatory reaction, over-production of osteopontin, early and prominent dystrophic calcification, and impaired hepatocyte scattering/migration into diseased areas. These studies provide direct genetic evidence in support of the critical role of c-met in efficient liver regeneration and suggest that disruption of c-met affects primarily hepatocyte survival and tissue remodeling.
Footnotes
-
↵ † To whom correspondence should be addressed. E-mail: snorri_thorgeirsson{at}nih.gov.
-
↵ * C.-G.H. and V.M.F. contributed equally to this work.
-
This paper was submitted directly (Track II) to the PNAS office.
-
Abbreviations: HGF/SF-Met, hepatocyte growth factor/scatter factor c-met signaling pathway; rhHGF, recombinant human HGF; AlbCre, albumin-Cre; PB, phenobarbital; PH, partial hepatectomy; uPA, urokinase-type plasminogen activator.
- Copyright © 2004, The National Academy of Sciences





